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Mice given pharmacological levels of the synthetic estrogen diethylstilbestrol demonstrated a marked
increase in susceptibility to infection with Listeria monocytogenes. Experiments were performed in an effort to
determine the mechanism(s) by which estrogen treatment increases the susceptibility of mice to L. monocyto-
genes infection. Estrogen exposure depressed the in vivo proliferative response of splenic lymphocytes to L.
monocytogenes, which correlated with the decreased in vitro response of these cells to phytohemagglutinin.
Interleukin 2 (IL 2) production by splenic lymphocytes from estrogen-treated mice was decreased, although
these cells were capable of proliferating normally in response to exogenous IL 2. Interleukin 1 production by
peritoneal macrophages was not depressed by estrogen exposure. The number of bacteria observed in the
spleens of estrogen-exposed mice challenged with L. monocytogenes was reduced by IL 2 administration. Thus,
estrogens may decrease host resistance to L. monocytogenes by inhibiting IL 2 production and the subsequent
proliferation of antigen-sensitized T lymphocytes required for recovery.
Estrogenic compounds are commonly encountered in the
environment. For example, diethylstilbestrol (DES), a syn-
thetic nonsteroidal estrogen, was extensively used as a
growth-promoting agent in the sheep and cattle industries
(reviewed in reference 26). In addition, DES has been widely
used in humans as an antiabortive agent, to control meno-
pausal symptoms, to suppress lactation, to prevent post-
coital implantation, and to treat breast cancer and prostate
cancer (4, 31). The toxicological effects associated with the
therapeutic use of DES include mixed adenosquamous car-
cinomas of the uterus (4) and clear-cell adenocarcinomas of
the vagina in young women exposed in utero (11). In
addition, immunosuppression after exposure to therapeutic-
dose levels of estrogen has been demonstrated in humans
(reviewed in reference 14) and animals (reviewed in refer-
ence 25).
Observations of sex differences in host resistance to
infectious agents have prompted numerous studies dealing
with the effects of estrogens on infectious disease processes
(e.g., 5, 7, 29, 30, 35, 37). These studies have clearly
indicated that therapeutic and, in some instances physiolog-
ical, levels of estrogens alter host susceptibility to selected
agents. Although the underlying mechanisms are not well
understood, such phenomena presumably reflect estrogen-
induced immunosuppression. In this respect, it has been
suggested that estrogens modulate T-cell maturation by
interfering with normal thymic hormone production (9, 24,
27). Previous work in this laboratory indicated that de-
creased host resistance to infectious agents, particularly
Listeria monocytogenes, is one of the most sensitive patho-
logical indicators of altered estrogen levels in mice (34).
Increased susceptibility to L. monocytogenes infection oc-
curred in mice exposed to DES or 17,B-estradiol at dose
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levels as low as 0.04 ,umol (34). Furthermore, in studies with
ovariectomized mice restored with estradiol 17p-cypionate it
was noted that although physiological levels of estrogens did
not influence resistance to either L. monocytogenes or
Toxoplasma gondii, abnormal physiological levels, like
those that occur during pregnancy, increased susceptibility
(0. J. Pung and M. I. Luster, Exp. Parasitol., in press).
Earlier, Luft and Remington (21) reported that pregnant
mice are more susceptible to both of these organisms.
The present studies were performed to investigate in detail
the relationship between estrogen-induced immunosuppres-
sion and altered host susceptibility to L. monocytogenes.
The in vitro and in vivo effects of estrogen on lymphoblas-
togenesis were investigated, as were the roles of interleukin
1 (IL 1) and interleukin 2 (IL 2) in altered host resistance.
MATERIALS AND METHODS
Mice. Specific-pathogen-free B6C3F1 (C57BL/6 x C3H/
He) female mice were obtained under a National Cancer
Institute production contract from Charles River Breeding
Laboratories, Inc., Portage, Mich. Animals were 8 to 10
weeks of age and weighed an average of approximately 20 g
at the time of these studies. They were maintained on a 12-h
light-dark cycle at 20 to 23°C and were provided with water
and autoclaved food (Ziegler Brothers, Inc., Gardner, Pa.) ad
libitum.
Bacterium. L. monocytogenes L242/73 type 4B from a
naturally infected mouse was stored at -70°C in nutrient
broth plus 15% glycerol. For infection of mice, a sample of
the frozen stock was thawed and diluted in Hanks balanced
salt solution, and 104 CFU were injected intravenously via
the tail vein.
Chemical-exposure regimen. Mice were treated with DES
(Sigma Chemical Co., St. Louis, Mo.) daily for five consec-
utive days. The chemical was dissolved in corn oil with
gentle heating and diluted such that each mouse received a
daily volume of 0.1 ml of corn oil subcutaneously in the
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dorsal cervical region. Controls received an equal volume of
corn oil. Studies were begun 3 to 5 days after the last dose.
Preparation of lymphoid cell suspensions. The culture me-
dium used in these experiments, henceforth referred to as
complete medium (CM), consisted of RPMI 1640 culture
medium containing 25 mM N-2-hydroxyethylpiperazine-N'-
2-ethanesulfonic acid (HEPES) buffer, 2 mM L-glutamine
(GIBCO Laboratories, Grand Island, N.Y.), and 50 ,ug of
gentamicin sulfate (Sigma) per ml. CM was supplemented
with fetal calf serum (FCS; GIBCO) or human AB serum as
indicated below. Single cell suspensions of spleens or thy-
mus glands were prepared by mashing the organ in 1 ml of
CM supplemented with 10% FCS with the plunger end of a
syringe. The cells were passed through a 25-gauge needle
into a 4-ml culture tube. Clumped cells were allowed to settle
for 2 min, and 0.2 ml of the supernatant fluid containing
suspended cells was placed in 2 ml of fresh CM. Nucleated
cells were enumerated with a Coulter Counter (Coulter
Electronics, Inc., Hialeah, Fla.), and their viability was
always >95%, as assessed by trypan blue exclusion.
Cell identification. Cytocentrifuged preparations stained
with Diff-Quik (American Scientific Products, McGaw Park,
Ill.) were used to determine the percentages of lymphocytes,
macrophages, and polymorphonuclear leukocytes. B and T
cells were enumerated by fluorescence staining. Briefly,
gradient-separated spleen cells (Lympholyte M; Accurate
Chemical and Scientific Corp., Westbury, N.Y.) were
washed three times in phosphate-buffered saline containing
5% FCS and adjusted to a concentration of 2 x 107 cells per
ml. Samples (0.05 ml) of cells were placed in microconical
tubes, and 0.05 ml of a 1/10 dilution of fluorescein isothio-
cyanate-conjugated anti-Thy 1.2 or rabbit antimouse immu-
noglobulin (Litton Bionetics, Kensington, Mo.) was added.
After incubation for 30 min at 23°C, the cells were washed,
the supernatant fluid was decanted, and the cells were mixed
with 0.1 ml of phosphate-buffered saline containing 10%
glycerol. A total of 200 cells per sample were counted with a
Leitz fluorescence microscope.
Mitogen assay. The ability of lymphocytes to respond to
mitogens was determined by a microculture assay as previ-
ously described (22). Purified phytohemagglutinin (PHA;
Burroughs Wellcome Co., Research Triangle Park, N.C.)
and Escherichia coli lipopolysaccharide (LPS; serotype
0111:B4; Sigma) were used as stimulators at various con-
centrations. At 6 h before culture termination, 1.0 p.Ci of
tritiated thymidine ([3H]TdR; New England Nuclear Corp.,
Boston, Mass.) was added to each well. The cells were
harvested, and [3H]TdR incorporation was determined by
liquid scintillation spectroscopy.
IL 1. IL 1 was produced and quantitated by a modification
of the method of Meltzer and Oppenheim (27). Peritoneal
exudate cells were obtained by peritoneal lavage of mice
with 10 ml of Ca2+- and Mg2+-free Hanks balanced salt
solution containing 10 U of sodium heparin per ml. The cells
were centrifuged for 10 min at 500 x g and adjusted to a
concentration of 106/ml in CM containing 5% FCS
(IlyClone; Sterile Systems, Logan, Utah) and 2.5 x 10-5 M
2-mercaptoethanol (2-ME). Aliquots (7 ml) of suspended
cells were incubated in 25-cm2 tissue culture flasks at 37°C in
a humidified atmosphere containing 5% CO2. After 2 h, the
flasks were rinsed three times with CM to remove nonadher-
ent cells and refilled with 7 ml of CM containing 5% FCS, 2.5
x l0-5 M 2-ME, and 50 ,ug of LPS per ml. After 2 days
of incubation, the supernatants were collected, dialyzed
against CM, filter sterilized, and frozen at -20°C. For
quantitation of IL 1 in these preparations, pooled thymo-
cytes were added to triplicate wells of flat-bottom, 96-well
microtiter plates in 0.05-ml volumes (1.5 x 106 cells) in CM
containing 5% human AB serum and 2.5 x 1i-5 M 2-ME. IL
1 preparations were diluted in this medium and added to the
wells in 0.1-ml volumes to produce final IL 1 dilutions of 1:2,
1:4, and 1:8. PHA in CM was then added in 0.05-ml volumes
to yield a final concentration of 2 ,ug/ml. Plates were incu-
bated for 72 h at 370C in 5% C02-air and pulsed with 1 ,uCi
of [3H]TdR 18 h before harvest.
IL 2. For some experiments, IL 2 was produced by a
modified version of the technique of Hoffenbach et al. (12).
Mouse spleen cells, adjusted to a concentration of 5 x 106/ml
in CM containing 5% human AB serum, S x 10-5 M 2-ME,
and 2 p,g of conconavalin A (ConA; Sigma) per ml, were
added in 7-ml volumes to 25-cm2 tissue culture flasks. The
cells were incubated for 24 h, after which the supernatant
were collected, treated with 0.1 M a-methyl-D-mannoside
(Sigma), filter sterilized, and frozen at -20°C. Human re-
combinant IL 2 (Genzyme Corp., Boston, Mass.) was used
as a standard and for in vivo restoration experiments. In the
restoration experiments, mice were inoculated intraperito-
neally with 1,500 U of recombinant IL 2 in 0.5 ml of saline on
the day of L. monocytogenes infection; control mice re-
ceived saline.
IL 2 preparations were tested against ConA blast cells as
follows. Aliquots (2 ml) of spleen cells (106/ml) were incu-
bated for 72 h in CM containing 5% human AB serum, 5 x
10-5 M 2-ME, and 2 ,ug of ConA per ml. After incubation,
the cells were washed twice in CM containing 5% human AB
serum and 0.1 M a-methyl-D-mannoside, and their viability
was determined by trypan blue exclusion. Cells in CM
containing 5% human AB serum and S x 10-5 M 2-ME were
added to triplicate wells of flat-bottom microtiter plates in
0.1-ml volumes (3 x 104 cells). IL 2 preparations were
diluted in this medium and added to the wells in 0.1-ml
volumes. The cells were cultured for 72 h and pulsed with 1.0
,uCi of [3H]TdR 6 h before harvest.
Statistical analysis. The chi-square test was used to assess
the significance of treatment effects in L. monocytogenes
mortality studies. For single comparisons of means, Stu-
dent's t test was used. For multiple comparisons of means,
significance levels were determined by a one-way analysis of
variance (ANOVA), and means were compared by the
least-significant-difference (LSD) test (40).
RESULTS
The total number of nucleated spleen cells in estrogen-
exposed and control mice was quantitated at various times
after L. monocytogenes infection to determine the effects of
estrogen on leucocyte accumulation at infective foci (Fig. 1).
The total number of nucleated spleen cells in uninfected
controls remained at approximately the same level through-
out the course of the experiment. Total spleen cell numbers
in both infected and uninfected DES-exposed mice, although
initially higher than that in uninfected controls, progres-
sively declined throughout the experiment. In contrast,
spleen cell numbers in infected controls increased to levels
significantly higher than those observed in both uninfected
controls and infected DES-exposed mice by day 4 after
infection and rose to even higher levels by day 6. This
increase in spleen cell numbers was primarily due to an
increase in the number of immunoglobulin- and Thy 1.2-
positive lymphocytes (Table 1). By day 6 after infection,
immunoglobulin- and Thy 1.2-positive spleen cell numbers
were significantly higher in infected controls than in either
uninfected controls or infected DES-exposed mice. Macro-
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TABLE 2. Effect of DES exposure on the ability of spleen cells
T from B6C3F, female mice to produce IL 2
202 4 6
DAYS AFTER INFECTION
FIG. 1. Effect of DES or L. monocytogenes infection or both on
total nucleated spleen cell numbers in uninfected mice given corn oil
(@) or 3 ,umol of DES (D) or in infected mice given corn oil (A) or
3 ,umol of DES (V). Mice were inoculated intravenously with 104 L.
monocytogenes cells 4 days after the final chemical treatment. Each
value represents the mean ± 1 standard error for at least eight mice.
Asterisks indicate significantly differences from uninfected controls
(P < 0.05). Daggers indicate significant differences from infected
mice given corn oil (P < 0.05).
phage numbers were also significantly higher in infected
controls on day 6, whereas the number of polymorphonu-
clear leukocytes was higher in infected DES-exposed mice.
A series of experiments was performed to determine the
mechanism by which estrogens suppress lymphocyte accu-
mulation and proliferation at infective foci. Spleen cells from
estrogen-exposed mice were cultured with mitogens to quan-
titate their proliferative capacity. As has previously been
demonstrated (22, 24), exposure to 3.0 ,umol of DES signif-
icantly depresses the ability of splenic lymphocytes to re-
spond to the T-cell mitogen PHA and the B-cell mitogen LPS
(data not shown). The effect of DES exposure on the
production of IL 2 was examined by obtaining supernatant
containing IL 2 from ConA-incubated cultures of splenic
lymphocytes of DES-treated or control mice. IL 2 produc-
tion was quantitated by measuring the ability of the super-
[3H]TdR incorporated (cpm x 103)b by ConA




0 22.7 ± 1.7 13.7 ± 2.2
0.07 8.5 ± 1.7 (37)C 3.0 ± 0.7 (22)C
0.74 7.0 ± 0.9 (30)C 2.1 ± 0.3 (15)C
3.00 4.3 ± 0.7 (13)C 2.4 ± 0.3 (17)C
a Mice were treated with DES for 5 days. Controls received corn oil.
b Three days after the final treatment with DES or corn oil, spleen cells
from exposed or control mice were cultured with 2 Fig of ConA per ml to
produce IL 2 supernatants. Supernatants were tested for the presence of IL 2
by measuring their ability to stimulate the proliferation of blast cells prepared
from the spleens of unexposed mice. Each value represents the mean ± 1
standard error for two sets of pooled spleen cells used to produce IL 2
supernatants (three mice per pool). Numbers in parentheses represent per-
centages relative to control mice. The value for medium-treated controls was
2.4 cpm x 103.
C Significantly different from controls (P < 0.05) as determined by Student's
t test.
natant to support ConA blast cell proliferation. It was
observed that IL 2 supernatant produced from lymphocytes
of DES-exposed mice did not stimulate ConA blast cell
proliferation to the same degree as IL 2 supernatant from
control lymphocytes and that this decrease in IL 2 produc-
tion was dose dependent (Table 2). Blast cell proliferation in
the presence of a 1:2 dilution of IL 2 supernatant fluid
produced from lymphocytes of mice exposed to 0.07, 0.74 or
3.0 ,umol of DES was approximately 37, 30, and 13%,
respectively, of the control values.
The effect of DES exposure on the response of lympho-
cytes to IL 2 was examined by culturing ConA blast cells
produced from splenic lymphocytes of mice exposed to 3.0
,umol of DES in the presence of IL 2. The proliferative
response of ConA blast cells prepared from the spleens of
DES-exposed mice was only slightly lower (not significantly)
than that of the control blast cells (Table 3).
To directly examine the effect of IL 2 on the estrogen-
mediated increase in susceptibility of mice to L. monocyto-
genes, we inoculated DES-exposed mice intraperitoneally
with 1,500 U of human recombinant IL 2 on the day of L.
monocytogenes infection. Four days later, the number of
splenic bacteria was determined. IL 2 partially restored host
resistance to L. monocytogenes in DES-exposed mice (Fig.
2). Although the number of bacteria observed in the spleens
of DES-treated and DES-treated, IL 2-treated mice was
significantly higher than the number observed in corn oil
controls, bacterial counts in the spleens of mice treated with
TABLE 1. Effect of DES exposure on differential spleen cell counts 6 days after L. monocytogenes infection
No. of cells per spleen (107)b
Mice' Immuno- Thy 1.2 Macro- Polymorpho-Total globulin psthye1.2hacro- nuclear leu-ppositive ositive phages kocytes
Uninfected control 16.6 ± 0.8 5.4 ± 0.8 5.4 ± 0.5 0.4 ± 0.1 0.3 ± 0.1
Uninfected DES exposed 14.4 ± 1.0 5.1 ± 0.5 5.1 ± 0.4 0.4 ± 0.1 0.3 ± 0.1
Infected control 31.0 ± 2.8C 10.3 ± 1.3C 13.2 + 2.0c 2.2 ± 0.3c 1.3 ± 0.2
Infected DES exposed 15.9 ± 1.2d 5.6 ± 0.7d 5.6 ± 0.7d 1.2 ± 0.2 2.6 ± 0.3 d
a Mice were treated for 5 days with 3.0 ,umol of DES. Controls received corn oil. Mice were inoculated intravenously with 104 L. monocytogenes cells 4 days af-
ter the final DES treatment.
b Each value represents the mean ± 1 standard error for at least eight mice.
c Significantly different from uninfected controls (P < 0.05) as determined by the LSD test based on a one-way ANOVA.
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TABLE 3. Response of ConA blast cells from DES-exposed mice
to IL 2
[3H]TdR incorporation (cpm x 103)b by cells
treated with:
Blast cell source' IL 2 (U/ml)Medium
(controls) 250 500
Control mice 0.4 ± 0.1 7.6 ± 0.8 20.8 ± 1.2
DES-treated mice 0.6 ± 0.1 5.9 ± 1.2 14.0 ± 4.8
a Mice were treated for 5 days with 3.0 ,umol of DES. Controls received
corn oil. Four days later, the spleens were removed, and blast cells were
prepared as described in Materials and Methods.
b Each value represents the mean ± 1 standard error for four sets of blast
cells prepared from the spleens of individual mice.
both DES and IL 2 were lower than in mice treated with
DES alone.
Peritoneal macrophages from mice exposed to 3.0 pimol of
DES were cultured in the presence of LPS to determine if
estrogen exposure affected IL 2 production by depressing
the production of IL 1. IL 1 production was quantitated in








CORN OIL CORN OIL DES DES
l1-2 IL -2
FIG. 2. Effect of IL 2 on susceptibility to L. monocytogenes
after DES exposure. Mice were inoculated intravenously with 104 L.
monocytogenes cells 4 days after treatment with 0.4 ,umol of DES.
On the day of infection, 1,500 U of IL 2 was injected intraperitone-
ally. Each value represents the mean + 1 standard error for eight
mice. Asterisks indicate significant differences from mice treated
only with corn oil (P < 0.05) as determined by the LSD test based
on a one-way ANOVA. Daggers indicate significant differences from
mice treated only with DES (P < 0.05) as determined by the LSD
test based on a one-way ANOVA.
proliferative response of normal thymocytes to PHA. Mac-
rophages from DES-treated mice were not suppressed in
their ability to produce IL 1 and, in fact, were slightly more
stimulatory to thymocyte proliferation than were control
supernatants (Table 4).
DISCUSSION
The ability of mice to resist L. monocytogenes infection
depends primarily on cell-mediated immune responses. Re-
covery is thought to require the accumulation of large
numbers of macrophages at infective foci (28, 32) and
macrophage activation by T-cell-produced lymphokines (15,
19). The immunological alterations associated with estrogen
exposure are consistent with decreased resistance to Listeria
strains resulting from altered macrophage and T-cell func-
tions (reviewed in reference 25). Indirect evidence that
estrogens disrupt the T-cell-mediated immune response to L.
monocytogenes but not the bactericidal properties of nonim-
mune macrophages was provided in earlier studies in which
the growth of bacteria was monitored in the spleens of
estrogen-exposed mice (5, 34). Substances directly toxic to
macrophages may result in greater numbers of bacteria in
infective foci as early as 24 h after infection. Compounds
toxic to components of the cell-mediated immune system are
evidenced by greater numbers of bacteria in infective foci
only later in the infection, when recovery requires T-cell
activation (37). As shown previously (5, 34), the number of
L. monocytogenes cells in the spleens of estrogen-treated
mice is greater than the number observed in control mice on
days 4 and 7 but not day 1 after infection. This indicates that
estrogen-mediated alteration of the immune response to L.
monocytogenes is mediated through the disruption of T-cell
function and not of the bactericidal properties of resident
macrophages. Furthermore, we have also shown that estro-
gen exposure does not decrease the bactericidal capacity of
nonimmune macrophages (0. J. Pung and M. I. Luster,
unpublished observations).
The effects of estrogens on T cells are multifold. For
example, estrogens produce thymic involution characterized
by depletion of cortical thymocytes (1, 6). Estrogens also
affect T-cell function, as evidenced by suppressed delayed
hypersensitivity and in vitro lymphoproliferative responses
to allogeneic leukocytes and T-cell mitogens (22, 24). In vitro
exposure to estradiol depresses the ability of splenic lym-
TABLE 4. Effect of DES exposure on the ability of macrophages
to produce IL 1
[3H]TdR incorporation (cpm x l03)b at
Source of test indicated dilution of test supernatant
supernatanta 1:2 1:4
Medium 5.0 + 0.4 NDc
Control cells 21.6 ± 3.0 13.9 ± 0.2
DES-treated cells 29.4 + 3.0 25.0 4.2d
a Mice were treated for 5 days with 3.0 1lmol of DES. Three days later,
supernatants containing IL 1 were prepared by culturing adherent peritoneal
exudate cells from control or treated mice in complete medium containing 50
jg of LPS per ml. The medium contained LPS at amounts equivalent to those
present in supernatants from cultured adherent cells.
b IL 1 production was quantitated by measuring the proliferative response
of control thymocytes to test supernatants and 2 jig of PHA per ml. Each
value represents the mean + 1 standard error for two experiments with
thymocytes pooled from 10 mice.C ND, Not done.
d Significantly different from control cells (P < 0.05) as determined by the
LSD test based on a one-way ANOVA.
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phocytes to produce IL 2 (10). In the present studies it was
noted that whereas splenic-lymphocyte numbers increased
dramatically in control mice exposed to L. monocytogenes,
splenic-lymphocyte numbers in infected DES-exposed mice
failed to rise above the level observed in uninfected controls
(Table 1 and Fig. 1). The increase in splenic lymphocytes in
infected controls was, to a large part, due to an augmentation
of the number of splenic T cells. Although macrophage
accumulation at infective foci primarily results from an
influx of circulating monocytes (32), the increase in splenic T
cells during infection is thought to be mainly due to T-cell
proliferation in the spleen (33, 39). The present studies
demonstrated that estrogens inhibit the proliferation of sple-
nic T cells during infection, an observation which probably
correlates with the inability of splenic T cells from estrogen-
treated mice to proliferate in response to T-cell mitogens. It
was also found that estrogens, although not affecting the
ability of blast cells to respond to IL 2, lead to the inhibition
of IL 2 production by these cells (Tables 2 and 3). It is
reasonable to suggest, therefore, that the depression of
T-cell proliferation described above is a consequence of an
estrogen-induced defect in IL 2 production.
Several lines of evidence support a role for IL 2 in
recovery from L. monocytogenes infection. First, L. mono-
cytogenes-sensitized Lyt 1+23- cells in the presence of IL 2
clonally expand to produce an enlarged population of cells
capable of transferring L. monocytogenes immunity (18),
and this population increases in the spleens of L. monocy-
togenes-infected mice (39). Second, Lyt 1+23- cells are
potent producers of IL 2 (8, 16) and, in the presence of IL 2,
proliferate to produce lymphokines, including macrophage-
activating factor (3) and migration inhibitory factor (17), vital
to recovery from Listeria infections.
Inoculation of mice with IL 2 partially reversed the effects
of estrogen on resistance to L. monocytogenes infection.
This suggests that the ability of estrogens to depress IL 2
production is directly related to the increase in the suscep-
tibility of mice to the bacterium. Presumably, a decrease in
the ability of lymphocytes from estrogen-exposed mice to
produce IL 2 would depress the proliferation of L. monocy-
togenes-sensitized T cells and, as a result, depress the
production of lymphokines responsible for effector-cell ac-
cumulation, macrophage activation, and granuloma forma-
tion at infective foci. This would permit bacterial growth to
proceed relatively unchecked. Depression of the production
of lymphokines such as migration inhibitory factor or che-
motactic factor may be reflected by the previously demon-
strated inability of estrogen-exposed mice to accumulate
monocytes at infective foci at the same rate as control mice
(34).
To investigate potential mechanisms by which estrogens
might depress IL 2 production, we examined the effects of
DES on IL 1. IL 1 plays an important role in the induction of
IL 2 by serving as a second signal for T-cell activation (20).
In the absence of IL 1, proliferation of antigen-sensitized T
cells is inhibited and IL 2 production is depressed (20). It
was found, however, that the ability of macrophages from
DES-exposed mice to produce IL 1 was not impaired (Table
4). There are other mechanisms by which estrogen exposure
might decrease IL 2 production; for example, there is
evidence that DES decreases total splenic-T-cell numbers
and, more specifically, depresses the percentage of Lyt
1+23- cells relative to Lyt 123+ and Lyt 1-23+ cells (13). As
Lyt 1+23- cells produce IL 2 (8), a decrease in their
numbers, combined with an increase in the regulatory sup-
pressor-T-cell population, would result in decreased IL 2
production. In light of the evidence that estrogens alter
thymic hormones (9, 23, 24, 36), it should be noted that
thymic hormones and IL 2 act in concert for normal matu-
ration of intrathymic lymphocytes and that thymus humoral
factor promotes IL 2 production (2, 38).
In conclusion, increased susceptibility to L. monocyto-
genes after exposure of mice to estrogens such as DES is not
mediated by alterations in nonimmune macrophage func-
tions. Rather, estrogens appear to inhibit both the in vitro
proliferative response of spleen cells to T-cell mitogens and
T-cell proliferation in the spleens of L. monocytogenes-
infected mice. This is due to depressed IL 2 production, the
importance of which is demonstrated by partial restoration
of normal host resistance in estrogen-treated mice by IL 2.
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